TMIGD2 Antilichaam (7A10]

TMIGD2 Antibody: TMIGD2 (transmembrane and immunoglobulin domain containing 1), also known as immunoglobulin-containing and proline-rich receptor 1 (IGPR1), is novel adhesion molecule that is expressed in multiple tissues, primarily in cells of epithelium and endothelium origins (1) . TMIGD2 is thought to be involved in angiogenesis and regulates cellular morphology, homophilic cell aggregation, and cell-cell interaction. TMIGD2 activity also modulates actin stress fiber formation and focal adhesion and reduces cell migration.

126259

Q96BF3

NP_653216

Human

TMIGD2 antibody was raised against the extracellular domain of human TMIGD2

7A10

Unconjugated

Primary Antibodies

Immunology, Stem Cell

TMIGD2 Antibody is supplied as protein A purified IgG1.

1 mg/mL

TMIGD2 Antibody is supplied in PBS containing 0.02% sodium azide and 50% glycerol.

None

Blue Ice

TMIGD2 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG1, k

TMIGD2 antibody can be used for Immunocytochemistry start at 2 μ g/mL. For Immunofluorescence start at 20 μ g/mL. For Immunohistochemistry start at 5 μ g/mL.

TMIGD2

Transmembrane and immunoglobulin domain containing 2

Homo sapiens

Rahimi N, Rezazadeh K, Mahoney JE, et al. Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis. Mol. Biol. Cell 2012; 23:1646-56.

IGPR1, IGPR-1, IGPR1, UNQ3059/PRO9879, Transmembrane and immunoglobulin domain-containing protein 2, Immunoglobulin and proline-rich receptor CD28 homolog, CD28H

ICC, IF, IHC-P

126259

Liquid